InsidersTradesSigma
프로티아 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 프로티아 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 프로티아 has logged 29 insider filings. Market capitalisation: €62.7bn. The latest transaction was disclosed on 10 April 2026 (Purchase). Among the most active insiders: 임국진. Every trade is openly available.
29
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
€79,219
4 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,439 of 28,168 companies
71.9
score / 100
Value58
Quality86
FCF yld2.9%
Earn yld6.9%
EV/EBITDA13.8x
ROE16%
Gross mgn62%
Net mgn30%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 10 April 2026
Declarations29 total
292,881 sharesKRXDART:20240715000351
25 of 29 declarations
About 프로티아
Protia is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance patient health.